Lim’s team, who studied melanoma patients receiving ICIs, identified 11 plasma cytokines (including granulocyte–colony-stimulating factor [G-CSF], granulocyte–macrophage colony–stimulating factor [GM–CSF], and IL–13) that dynamically increase before or during the onset of high-grade irAEs (86). The gene discussed is CSF3; the disease is melanoma.